Clinical Trials Directory

Trials / Unknown

UnknownNCT02327780

The Effectivness of FODMAP Diet in Israel in Relieving Symptoms of Patients With Irritable Bowel Syndrome

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
18 Years – 77 Years
Healthy volunteers
Not accepted

Summary

Treatment of IBS is very problematic. Despite the wide range of pharmacological and non-pharmacological therapies, there is no universally accepted approach. In recent years, the low FODMAP diet has been developed, a dietary approach that aims to relieve the symptoms of IBS. FODMAPs (Fermentable Oligosaccharides, Di-saccharides, Mono-saccharides and Polyols) are a group of dietary sugars that may be poorly absorbed in the small intestine and fermented by bacteria to produce gas. Ingestion of FODMAPs may also result in alterations in fluid content in the colon and trigger functional gut symptoms in some individuals. This study aims to examine the effectiveness of the FODMAP diet in Israel in improving symptoms of IBS compared to the standard dietary advice.

Conditions

Interventions

TypeNameDescription
OTHERFODMAP diet

Timeline

Start date
2015-01-01
Primary completion
2016-01-01
Completion
2016-03-01
First posted
2014-12-30
Last updated
2014-12-30

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02327780. Inclusion in this directory is not an endorsement.

The Effectivness of FODMAP Diet in Israel in Relieving Symptoms of Patients With Irritable Bowel Syndrome (NCT02327780) · Clinical Trials Directory